[Efficacy of flunisolide in treatment of patients with bronchial asthma]. 1995

B Romański, and A Krymer, and P Grabowski, and A Dziedziczko
Katedry i Kliniki Alergologii i Chorób Wewnetrznych, Akademii Medycznej w Bydgoszczy.

In 30 patients with bronchial asthma an influence of flunisolid (Bronilide) on spirometric values, bronchial reactivity and pathological signs was evaluated. No changing in spirometric values and bronchial reactivity and decrease complaints during the treatment with higher doses of Bronilide were noticed. No significant side effects were observed.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005446 Fluocinolone Acetonide A glucocorticoid derivative used topically in the treatment of various skin disorders. It is usually employed as a cream, gel, lotion, or ointment. It has also been used topically in the treatment of inflammatory eye, ear, and nose disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p732) Fluortriamcinolone Acetonide,Alvadermo,Capex,Co-Fluocin,Cortiespec,Derma-Smooth FS,Flucinar,Fluocid,Fluodermo,Fluonid,Fluotrex,Flurosyn,Flusolgen,Gelidina,Jellin,Jellisoft,Synalar,Synalar-HP,Synamol,Synemol,Acetonide, Fluocinolone,Acetonide, Fluortriamcinolone,Co Fluocin,Derma Smooth FS,Synalar HP
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

B Romański, and A Krymer, and P Grabowski, and A Dziedziczko
February 1979, Annals of allergy,
B Romański, and A Krymer, and P Grabowski, and A Dziedziczko
March 2001, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi,
B Romański, and A Krymer, and P Grabowski, and A Dziedziczko
May 2014, Expert review of clinical pharmacology,
B Romański, and A Krymer, and P Grabowski, and A Dziedziczko
February 2021, The Journal of asthma : official journal of the Association for the Care of Asthma,
B Romański, and A Krymer, and P Grabowski, and A Dziedziczko
August 1994, La Clinica terapeutica,
B Romański, and A Krymer, and P Grabowski, and A Dziedziczko
March 2003, Clinical therapeutics,
B Romański, and A Krymer, and P Grabowski, and A Dziedziczko
January 1985, The Journal of international medical research,
B Romański, and A Krymer, and P Grabowski, and A Dziedziczko
November 1990, Allergy,
B Romański, and A Krymer, and P Grabowski, and A Dziedziczko
June 1987, The Journal of allergy and clinical immunology,
Copied contents to your clipboard!